|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/167 | |
| A61K 31/18 | |||
| A61K 31/382 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Number of the document | 2544673 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11709273.4 |
| Date of filing the European patent application | 2011-03-08 | |
| (97) | Date of publication of the European application | 2013-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/027606 |
| Date | 2011-03-08 |
| (87) | Number | WO 2011/112623 |
| Date | 2011-09-15 |
| (30) | Number | Date | Country code |
| 311736 P | 2010-03-08 | US |
| (72) |
NAWROCKI, Steffan, T., US
CAREW, Jennifer, S,, US
REDDY, Guru, US
|
| (73) |
Spectrum Pharmaceuticals, Inc.,
157 Technology Drive, Irvine, CA 92618,
US
|
| (54) | THIOXANTHONE-BASED AUTOPHAGY INHIBITOR THERAPIES TO TREAT CANCER |
| THIOXANTHONE-BASED AUTOPHAGY INHIBITOR THERAPIES TO TREAT CANCER |